STOCK TITAN

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
NeuroMetrix, Inc. (NURO) will release its 2023 fourth quarter and year-end business and financial highlights on February 22, 2024. The company will conduct a conference call at 8:00 a.m. ET on the same day for participants to ask questions. Access to the call can be obtained by registering in advance. An audio-only webcast and financial statements will be available on the company's website. A replay of the call will also be accessible for one year.
Positive
  • None.
Negative
  • None.

WOBURN, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2023 fourth quarter and year end business and financial highlights before the opening of the market on February 22, 2024. The Company will host a conference call at 8:00 a.m., Eastern Time on February 22, 2024.

For participants who wish to access the Q4 and year end 2023 Conference Call live via telephone and be able to ask questions, please register in advance here. Upon registering, a dial-in and unique PIN will be provided on screen and via email to join the call. An audio-only webcast of the call, along with the earnings press release and accompanying condensed financial statements, may be accessed in the Investors section of the Company’s website at www.NeuroMetrix.com. Following the conference call, a replay of the call will be available for one year on the Company's Investors section of the website.

About NeuroMetrix

NeuroMetrix is a commercial stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell® is a wearable neuromodulation platform. DPNCheck® is a point-of-care screening test for peripheral neuropathy. For more information, visit www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.


FAQ

When will NeuroMetrix (NURO) release its 2023 fourth quarter and year-end business and financial highlights?

NeuroMetrix (NURO) will release its 2023 fourth quarter and year-end business and financial highlights on February 22, 2024.

What time will the conference call be held on February 22, 2024, for NeuroMetrix (NURO)?

The conference call for NeuroMetrix (NURO) will be held at 8:00 a.m. Eastern Time on February 22, 2024.

How can participants access the Q4 and year-end 2023 Conference Call live via telephone for NeuroMetrix (NURO)?

Participants can access the Q4 and year-end 2023 Conference Call live via telephone by registering in advance. Upon registration, a dial-in and unique PIN will be provided.

Where can the audio-only webcast of the call and financial statements be accessed for NeuroMetrix (NURO)?

The audio-only webcast of the call and financial statements can be accessed in the Investors section of NeuroMetrix's (NURO) website at www.NeuroMetrix.com.

For how long will the replay of the conference call be available for NeuroMetrix (NURO)?

The replay of the conference call will be available for one year on the Investors section of NeuroMetrix's (NURO) website.

NeuroMetrix, Inc.

NASDAQ:NURO

NURO Rankings

NURO Latest News

NURO Stock Data

7.97M
1.59M
25.45%
3.01%
2.08%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WALTHAM